104
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

Inhaled nintentanib, Pirfenidone and Macitentan for Pulmonary Fibrosis: a Laboratory Experiment

ORCID Icon, , , , , , , , , , , , , & ORCID Icon show all
Pages 491-498 | Received 18 Jun 2023, Accepted 02 Aug 2023, Published online: 16 Aug 2023
 

Abstract

Aim: Idiopathic pulmonary fibrosis is a rare disease with few efficient drugs in the market. The consequences of this disease are mainly respiratory failure and pulmonary hypertension. Materials & methods: In our experiment we used the drugs pirfenidone, nintetanib and macitentan. We performed nebulization experiments with three jet nebulizers and three ultrasound nebulizers with different combinations of residual cup designs, and residual cup loadings in order to identify which combination produces droplets of less than 5 μm in mass median aerodynamic diameter. Results: Pirfenidone versus nintetanib had smaller droplet size formation at both inhaled technologies (1.37 < 2.23 and 1.92 < 3.11, jet and ultrasound respectively). Discussion: Pirfenidone and nintetanib can be administered as aerosol in any type of nebulization system.

Supplementary data

To view the supplementary data that accompany this paper please visit the journal website at:www.tandfonline.com/doi/full/10.2217/epi-2016-0184

Author contributions

P Zarogoulidis, D Petridis, H Huang, C Bai, P Oikonomou, C Nikolaou, D Matthaios, E-Isidora Perdikouri, V Papadopoulos, S Petanidis, C Kosmidis, C Charalampidis, W Hohenforst-Schmidt, N Kougkas, C Sardeli wrote the manuscript, performed the experiments and collected the data. P Zarogoulidis and D Petridis performed the statistics.

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 351.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.